1Novo Nordisk A/S, Novo Nordisk Park, 2760 Maaloev, Denmark. phol@novonordisk.com
Bioisosteric replacement is a valuable strategy for optimizing drug leads. This technique refines compounds for clinical trials by enhancing target selectivity and improving pharmacokinetic properties.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: